New Diagnostic Methods and Treatments for Endometriosis
Focusing on Prognosis and Prevention of Complications
Led by Turku University Hospital · Updated on 2021-08-16
230
Participants Needed
4
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Endometriosis is a long-lasting condition where tissue similar to the lining inside the uterus grows outside it, causing pain and fertility problems for many women of reproductive age. This research aims to find specific RNA and protein markers in endometriosis tissue and normal uterine lining to help develop new treatments and diagnostic tools. The study also seeks to identify markers that predict disease progression and infertility through a detailed 10-year follow-up.
Participants include women aged 19 to 48 years either with surgically confirmed endometriosis or healthy women without endometriosis confirmed by laparoscopy during sterilization. The study involves collecting tissue samples during surgery by laparoscopy or laparotomy for analysis of hormone metabolism and gene expression. Healthy volunteers are also included to provide comparison samples.
During the study, researchers will collect samples during surgery and follow participants annually for up to 10 years using questionnaires about pain symptoms, fertility, and treatments. The study measures hormone levels and gene expression in tissues and blood, and tracks pain recurrence after surgery. This long-term follow-up aims to better understand disease behavior and support development of personalized treatment options.
CONDITIONS
Brief Title
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
Research Team
A
Antti H Perheentupa, MD PhD
K
Kaisa Huhtinen, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Study group: surgically and pathologically confirmed endometriosis
Control group: confirmed absence of endometriosis by laparoscopy
You will not qualify if you...
Presence of other significant diseases or medications for other conditions
Suspicion of malignancy
Currently pregnant
Acute infection
Insufficient understanding of Finnish language
Previous hysterectomy and/or removal of both ovaries
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Surgery and Immediate Post-operative Care
Duration - Day of surgery plus immediate recovery period
Participants undergo surgical procedures including laparoscopy or laparotomy for diagnosis and treatment of endometriosis, with sample collection during surgery.
1 surgical visit (in-person)
Long-term Monitoring
Duration - 5 years
Participants are followed for up to 5 years to monitor pain recurrence and other health outcomes after surgical treatment.
Annual visits for up to 5 years
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Similar Trials
Long-Term Study of Relugolix Combination Tablet to Monitor Bone Health in Premenopausal Women With Heavy Menstrual Bleeding From Fibroids or Pain From Endometriosis
A Randomized Controlled Study Testing a Whole Food Plant-Based Diet for Women Aged 18-45 With Endometriosis to Improve Pain and Quality of Life
Investigating the Link Between Endometriosis and Tissue Microbiota in Women Aged 18 to 52
Argon Plasma Treatment Versus Standard Cystectomy for Ovarian Endometrioma Surgery A Randomized Controlled Pilot Study
Integrating Artificial Intelligence with Ultrasound to Improve Diagnosis in Womens Reproductive Health
Evaluating a New High-CBD Treatment for Gynecologic Pain from Endometriosis, Adenomyosis, or PID
Evaluating GnRH Agonist Injections Before Frozen Embryo Transfer
for Women With Endometriosis andor Adenomyosis
Non-Invasive Protein Biomarkers Study for Diagnosis and Monitoring of Endometriosis in Women Ages 18 to 45
Study of Blood and Tissue Biomarkers to Improve Diagnosis and Outcomes in Women with Endometriosis
Study on Central Sensitisation Syndrome in Women Aged 18 to 50 With Endometriosis
Evaluating Symptoms and Risk Factors Using a Questionnaire
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Secreted frizzled-related protein 2 (SFRP2) expression promotes lesion proliferation via canonical WNT signaling and indicates lesion borders in extraovarian endometriosis.